Leading Companies
MSD Merck Sharp & Dohme AG
$40B pharmaceutical giant uses Lucerne as its largest base outside of the US, hosting its EMEA HQ serving 140 countries with 900+ FTEs. MSD conducts clinical research, focusing on cancer therapy R&D activities with its newest oncology product being manufactured in Lucerne.
Secteurs
Swiss Tech + Industries
Personalized Health
Central Functions
Chemical & Pharmaceutical Technology
Life Science
Country of Origin
Etats-Unis
En savoir plus sur le sujet
